Clinical Trial Update: A Dose-finding Study of RO5323441 in Patients With Metastatic Treatment-Refractory Colorectal or Ovarian Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 dose-finding study of RO5323441 in patients with metastatic, treatment-refractory colorectal or ovarian cancer. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Ovarian Cancer

Drugs mentioned

• RO5323441 (RO5323441)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED